As the quest for disease-modifying treatments intensifies, neuroprotective therapies are at the forefront of research. This track will cover the mechanisms of neuroprotection in movement disorders, including the use of antioxidants, inflammation modulation, and regenerative approaches like stem cell therapy. Attendees will also learn about new drug development efforts aimed at halting disease progression.
Track 8-1: Antioxidant Therapies in Movement Disorders
Track 8-2: Neuroinflammation Modulation
Track 8-3: Gene Therapy as A Neuroprotective Strategy
Track 8-4: Stem Cell Therapies for Neuroprotection
Track 8-5: Emerging Drug-Based Neuroprotective Strategies
Gain an understanding of the potential and challenges of neuroprotective agents, and how they may contribute to slowing disease progression in neurodegenerative movement disorders.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
